Tivic Health Systems Files 8-K on Financials
Ticker: TIVC · Form: 8-K · Filed: Aug 14, 2025 · CIK: 1787740
Sentiment: neutral
Topics: financial-reporting, operations, sec-filing
TL;DR
Tivic Health Systems dropped an 8-K on Aug 14th covering financials and operations.
AI Summary
Tivic Health Systems, Inc. filed an 8-K on August 14, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Fremont, California.
Why It Matters
This 8-K filing provides crucial updates on Tivic Health Systems' financial performance and operational status, which are important for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine 8-K filing providing financial and operational updates, not indicating any immediate material adverse events.
Key Players & Entities
- Tivic Health Systems, Inc. (company) — Registrant
- August 14, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Fremont, California (location) — Principal Executive Offices
- 888 276-6888 (phone_number) — Registrant's Telephone Number
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of these results are not provided in the provided text.
When was this 8-K report filed?
This 8-K report was filed on August 14, 2025.
What is the primary business of Tivic Health Systems, Inc. based on its SIC code?
Based on its SIC code [3845], Tivic Health Systems, Inc. is in the business of 'ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS'.
Where are Tivic Health Systems, Inc.'s principal executive offices located?
Tivic Health Systems, Inc.'s principal executive offices are located at 47685 Lakeview Blvd. Suite 100, Fremont, California, 94538.
Does this filing indicate any immediate regulatory actions or material events?
The filing is a 'Current Report' pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and includes 'Regulation FD Disclosure', suggesting adherence to disclosure rules, but does not specify any immediate adverse regulatory actions or material events in the provided text.
Filing Stats: 817 words · 3 min read · ~3 pages · Grade level 11.8 · Accepted 2025-08-14 16:02:19
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share TIVC The Nasdaq Stock Mar
Filing Documents
- tivc-20250814.htm (8-K) — 51KB
- tivc-ex99_1.htm (EX-99.1) — 182KB
- img553027_0.jpg (GRAPHIC) — 14KB
- 0000950170-25-108835.txt ( ) — 369KB
- tivc-20250814.xsd (EX-101.SCH) — 24KB
- tivc-20250814_htm.xml (XML) — 5KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. The information provided below in "Item 7.01 - Regulation FD Disclosure" of this Current Report on Form 8-K (this "Current Report") is incorporated by reference into this Item 2.02.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On August 14, 2025, Tivic Health Systems, Inc. (the "Company") issued a press release regarding the Company's financial results for its quarter ended June 30, 2025. A copy of that press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference. The information set forth under Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section. The information in Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing, except as expressly set forth by specific reference in such a filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.
Forward-Looking Statements
Forward-Looking Statements This Current Report, including Exhibit 99.1 attached hereto, contains certain forward-looking statements that involve substantial risks and uncertainties. When used herein, the terms "anticipates," "expects," "estimates," "believes," "will" and similar expressions, as they relate to us or our management, are intended to identify such forward-looking statements. Forward-looking statements in this Current Report, including Exhibit 99.1 attached hereto, or hereafter, including in other publicly available documents filed with the Securities and Exchange Commission, reports to the stockholders of the Company and other publicly available statements issued or released by us involve known and unknown risks, uncertainties and other factors which could cause our actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. Such future results are based upon management's best estimates based upon current conditions and the most recent results of operations. These risks include, but are not limited to, the risks set forth herein and in such other documents filed with the Securities and Exchange Commission, each of which could adversely affect our business and the accuracy of the forward-looking statements contained herein. Our actual results, performance or achievements may differ materially from those expressed or implied by such forward-looking statements.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated August 14, 2025. 104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TIVIC HEALTH SYSTEMS, INC. Date: August 14, 2025 By: /s/ Jennifer Ernst Name: Jennifer Ernst Title: Chief Executive Officer